
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253D468AF26863053D4600111B7497.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmjo">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMJ Open">
<meta name="citation_title" content="Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase">
<meta name="citation_author" content="Congcong Yu">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Huijie Yang">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Bing Zhang">
<meta name="citation_author_institution" content="Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Shihua Chen">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Sijue Yang">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Fangyi Li">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Wenhui Zhu">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Beibei Zhai">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Tianyu Wu">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Shengyi Zhao">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Wen Zhang">
<meta name="citation_author_institution" content="Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Xuewei Tong">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Yanjie Duan">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Lu Zhang">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Yining Chao">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Jindan Wu">
<meta name="citation_author_institution" content="Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Xiaowei Zhu">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Wuxi People&#x27;s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China">
<meta name="citation_author" content="Kun Wang">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Xinhua Ye">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China">
<meta name="citation_author" content="Xiaoya Zhang">
<meta name="citation_author_institution" content="Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Xiang Xu">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Wuxi People&#x27;s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China">
<meta name="citation_author" content="Haiyan Cheng">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Wuxi People&#x27;s Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China">
<meta name="citation_author" content="Jie Liu">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Jie Zhang">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China">
<meta name="citation_author" content="Ying Wang">
<meta name="citation_author_institution" content="Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China">
<meta name="citation_author" content="Zhou Zhang">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_author" content="Weili Yan">
<meta name="citation_author_institution" content="Department of Clinical Epidemiology, Children&#x27;s Hospital of Fudan University National Children’s Medical Center, Shanghai, Shanghai, China">
<meta name="citation_author" content="Yan Bi">
<meta name="citation_author_institution" content="Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China">
<meta name="citation_author_institution" content="Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e095382">
<meta name="citation_doi" content="10.1136/bmjopen-2024-095382">
<meta name="citation_pmid" content="40840993">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/pdf/bmjopen-15-8.pdf">
<meta name="description" content="Diabetes is a significant modifiable risk factor for cognitive dysfunction. There are currently no effective treatments that delay or reverse the progression of cognitive dysfunction. Accumulating evidence demonstrates that specific antidiabetes ...">
<meta name="og:title" content="Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Diabetes is a significant modifiable risk factor for cognitive dysfunction. There are currently no effective treatments that delay or reverse the progression of cognitive dysfunction. Accumulating evidence demonstrates that specific antidiabetes ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374654">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1136/bmjopen-2024-095382"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/bmjopen-15-8.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374654%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374654/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374654/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmjopen.png" alt="BMJ Open logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMJ Open" title="Link to BMJ Open" shape="default" href="http://bmjopen.bmj.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMJ Open</button></div>. 2025 Aug 21;15(8):e095382. doi: <a href="https://doi.org/10.1136/bmjopen-2024-095382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1136/bmjopen-2024-095382</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMJ%20Open%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMJ%20Open%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMJ%20Open%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMJ%20Open%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Congcong Yu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Congcong Yu</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Congcong Yu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Huijie Yang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Huijie Yang</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huijie Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Bing Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Bing Zhang</span></h3>
<div class="p">
<sup>3</sup>Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bing Zhang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shihua Chen</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shihua Chen</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chen%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shihua Chen</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Sijue Yang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Sijue Yang</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sijue Yang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Fangyi Li</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Fangyi Li</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fangyi Li</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Wenhui Zhu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Wenhui Zhu</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wenhui Zhu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhai%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Beibei Zhai</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Beibei Zhai</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhai%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Beibei Zhai</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Tianyu Wu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Tianyu Wu</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tianyu Wu</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Shengyi Zhao</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Shengyi Zhao</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shengyi Zhao</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Wen Zhang</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Wen Zhang</span></h3>
<div class="p">
<sup>3</sup>Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wen Zhang</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tong%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Xuewei Tong</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Xuewei Tong</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tong%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xuewei Tong</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Yanjie Duan</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Yanjie Duan</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duan%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yanjie Duan</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Lu Zhang</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Lu Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lu Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Yining Chao</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Yining Chao</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yining Chao</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Jindan Wu</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Jindan Wu</span></h3>
<div class="p">
<sup>4</sup>Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jindan Wu</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Xiaowei Zhu</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Xiaowei Zhu</span></h3>
<div class="p">
<sup>5</sup>Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaowei Zhu</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Kun Wang</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Kun Wang</span></h3>
<div class="p">
<sup>6</sup>Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kun Wang</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Xinhua Ye</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Xinhua Ye</span></h3>
<div class="p">
<sup>7</sup>Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ye%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xinhua Ye</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Xiaoya Zhang</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Xiaoya Zhang</span></h3>
<div class="p">
<sup>4</sup>Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoya Zhang</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Xiang Xu</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Xiang Xu</span></h3>
<div class="p">
<sup>5</sup>Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiang Xu</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Haiyan Cheng</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Haiyan Cheng</span></h3>
<div class="p">
<sup>5</sup>Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cheng%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haiyan Cheng</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id23"><span class="name western">Jie Liu</span></a><div hidden="hidden" id="id23">
<h3><span class="name western">Jie Liu</span></h3>
<div class="p">
<sup>6</sup>Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie Liu</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id24"><span class="name western">Jie Zhang</span></a><div hidden="hidden" id="id24">
<h3><span class="name western">Jie Zhang</span></h3>
<div class="p">
<sup>7</sup>Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jie Zhang</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id25"><span class="name western">Ying Wang</span></a><div hidden="hidden" id="id25">
<h3><span class="name western">Ying Wang</span></h3>
<div class="p">
<sup>7</sup>Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Ying Wang</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id26"><span class="name western">Zhou Zhang</span></a><div hidden="hidden" id="id26">
<h3><span class="name western">Zhou Zhang</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhou Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id27"><span class="name western">Weili Yan</span></a><div hidden="hidden" id="id27">
<h3><span class="name western">Weili Yan</span></h3>
<div class="p">
<sup>8</sup>Department of Clinical Epidemiology, Children's Hospital of Fudan University National Children’s Medical Center, Shanghai, Shanghai, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yan%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weili Yan</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id28"><span class="name western">Yan Bi</span></a><div hidden="hidden" id="id28">
<h3><span class="name western">Yan Bi</span></h3>
<div class="p">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div class="p">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Bi</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div id="aff2">
<sup>2</sup>Branch of National Clinical Research Centre for Metabolic Diseases, Nanjing, Jiangsu, China</div>
<div id="aff3">
<sup>3</sup>Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China</div>
<div id="aff4">
<sup>4</sup>Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div id="aff5">
<sup>5</sup>Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People’s Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China</div>
<div id="aff6">
<sup>6</sup>Department of Endocrinology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, Jiangsu, China</div>
<div id="aff7">
<sup>7</sup>Department of Endocrinology, The Affiliated Changzhou No 2 People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China</div>
<div id="aff8">
<sup>8</sup>Department of Clinical Epidemiology, Children's Hospital of Fudan University National Children’s Medical Center, Shanghai, Shanghai, China</div>
<div class="author-notes p">
<div class="fn" id="fn1"><p>Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.</p></div>
<div class="fn" id="fn4"><p>None declared.</p></div>
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Dr Yan Bi; <span>biyan@nju.edu.cn</span></p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 21; Accepted 2025 Jul 28; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</div>
<p>This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374654  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40840993/" class="usa-link">40840993</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Introduction</h3>
<p>Diabetes is a significant modifiable risk factor for cognitive dysfunction. There are currently no effective treatments that delay or reverse the progression of cognitive dysfunction. Accumulating evidence demonstrates that specific antidiabetes medications hold promise in improving cognitive function. However, the comparative effects of various antidiabetic drug classes on cognitive protection remain to be fully elucidated. This study aims to investigate and compare the cognitive benefits of liraglutide, empagliflozin and linagliptin on achieving mild cognitive impairment (MCI) remission in individuals with type 2 diabetes (T2D).</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods and analysis</h3>
<p>The LIGHT-MCI trial is an investigator-initiated, multicentre, open-label, parallel-group, randomised, superiority trial involving T2D patients with MCI, consisting of a 48-week core study followed by an extension phase through to 76 weeks. A total of 396 participants will be randomly allocated 1:1:1 to receive liraglutide, empagliflozin or linagliptin treatment. The primary outcome measure is the efficacy difference of liraglutide, empagliflozin and linagliptin in achieving MCI remission in individuals with T2D. The key secondary outcome measures include changes in scores of general cognition and various cognitive subdomains (including processing speed, executive function, immediate memory, visuospatial construction ability, language, attention and delayed memory), basic and instrumental daily living ability, MRI-derived normalised measures of total brain volume, cerebral microstructures, cortical and nuclear volume, white matter hyperintensity, volume, white matter microstructural integrity, odour-induced brain activation and resting-state functional connectivity, olfactory function and metabolic parameters.</p></section><section id="sec3"><h3 class="pmc_sec_title">Ethics and dissemination</h3>
<p>The LIGHT-MCI trial has received approval from the Ethics Committees of the Drum Tower Hospital Affiliated to Nanjing University Medical School (2022-092-02) and other participating centres in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonisation for Good Clinical Practice (ICH GCP E6). Informed consent is required for participation. Findings from this trial are disseminated through peer-reviewed publications, conference presentations, newsletters and social media.</p></section><section id="sec4"><h3 class="pmc_sec_title">Trial registration number</h3>
<p><a href="https://clinicaltrials.gov/ct2/show/NCT05313529" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05313529</a>.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Diabetes Mellitus, Type 2; Cognition; Dementia</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="BX1"><h2 class="obj_head">STRENGTHS AND LIMITATIONS OF THIS STUDY.</h2>
<ul class="list" style="list-style-type:disc">
<li><p>The multicentre randomised controlled design of the LIGHT-MCI study enhances internal validity and the generalisability of the study findings.</p></li>
<li><p>The three-arm design allows a head-to-head comparison of cognitive benefits of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors against an active control arm.</p></li>
<li><p>The primary outcome is assessed through a comprehensive neuropsychological battery administered by trained personnel, with prespecified mild cognitive impairment remission criteria, ensuring the validity of outcome measurements.</p></li>
<li><p>The secondary outcomes included alterations in brain structure and function, olfactory function and metabolic parameters, to indicate potential mechanisms underlying the cognitive benefits.</p></li>
<li><p>The study is a pragmatic open-label trial, with inevitable potential confounding bias.</p></li>
</ul></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p> The rapid aging of the global population has intensified the prevalence of both diabetes and dementia, emerging as critical public health challenges. Currently, there are approximately 537 million adults with diabetes worldwide, projected to rise to 783 million by 2045.<a href="#R1" class="usa-link" aria-describedby="R1"><sup>1</sup></a> Likewise, global dementia cases stand at around 55 million, with estimates indicating a surge to 151 million by 2050.<a href="#R2" class="usa-link" aria-describedby="R2"><sup>2 3</sup></a> Notably, diabetes significantly increases the risk of dementia by 1.5–2.5 times, and cognitive dysfunction is increasingly acknowledged as an emerging complication of diabetes.<a href="#R4" class="usa-link" aria-describedby="R4"><sup>4 5</sup></a></p>
<p>Regrettably, the currently available pharmacological therapies for delaying or reversing the progression of dementia have limited efficacy and undesirable side effects. Mild cognitive impairment (MCI) is deemed as the prodromal stage of dementia and constitutes a high-risk group for progression to dementia.<a href="#R6" class="usa-link" aria-describedby="R6"><sup>6 7</sup></a> Therefore, early identification and intervention of individuals with MCI is likely essential for successful disease prevention and progression mitigation. Although routine screening for the early detection of cognitive impairment is widely recommended, current clinical guidelines have not offered strategies to combat cognitive dysfunction.<a href="#R8" class="usa-link" aria-describedby="R8"><sup>8</sup></a></p>
<p>There is growing evidence that certain antidiabetes medications hold promise in improving cognitive function. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown potential in restoring brain glucose metabolism in Alzheimer’s disease, offering a putative repurposed candidate against cognitive dysfunction.<a href="#R9" class="usa-link" aria-describedby="R9"><sup>9 10</sup></a> Exploratory or post-hoc analyses of randomised trials suggest GLP-1 RAs versus placebo may protect against cognitive decline.<a href="#R11" class="usa-link" aria-describedby="R11"><sup>11</sup></a>,<a href="#R14" class="usa-link" aria-describedby="R14"><sup>14</sup></a> Also, the role of sodium-glucose cotransporter 2 (SGLT2) inhibitors in cognitive function has emerged as another focal point. Population-based cohort studies point to a significantly reduced risk of dementia associated with SGLT2 inhibitor usage, yet clear neuroprotective effects from prospective randomised controlled trials remain lacking.<a href="#R15" class="usa-link" aria-describedby="R15"><sup>15</sup></a>,<a href="#R18" class="usa-link" aria-describedby="R18"><sup>18</sup></a> Linagliptin, a dipeptidyl peptidases 4 (DPP4) inhibitor, showed neutral effects on cognition in the CARMELINA and CAROLINA-COGNITION trials.<a href="#R19" class="usa-link" aria-describedby="R19"><sup>19 20</sup></a> Accumulating studies have explored the cognitive benefits of a specific class of antidiabetic agents, yet there is limited evidence informing their head-to-head comparisons of cognitive effects. Our preliminary 16-week randomised trial comparing liraglutide, dapagliflozin and acarbose demonstrated liraglutide’s superior effects on restoring odour-induced brain activation and cognitive domains in type 2 diabetes (T2D) patients.<a href="#R21" class="usa-link" aria-describedby="R21"><sup>21</sup></a> However, these findings should be interpreted in light of methodological limitations including a modest sample size, short intervention period and reliance on neuroimaging surrogate endpoints.</p>
<p>Therefore, we have further designed a multicentre, randomised, superiority trial on head-to-head comparison of efficacy of liraglutide, empagliflozin and linagliptin on MCI remission in T2D. The results are expected to address knowledge gaps and inform clinical decision-making by providing robust evidence.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods and analysis</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Study design and setting</h3>
<p>The LIGHT-MCI study is an investigator-initiated, multicentre, open-label, parallel-group, randomised, superiority trial designed to evaluate the efficacy of three add-on therapies to metformin monotherapy for MCI remission in T2DM patients. Using a 1:1:1 allocation ratio, participants will be randomly assigned to receive either liraglutide, empagliflozin or linagliptin for the 48-week core study period. Those completing the core study may opt for an additional 28-week extension phase after providing informed consent, resulting in a total possible intervention duration of 76 weeks. The trial is registered at ClinicalTrials.gov (ID: <a href="https://clinicaltrials.gov/ct2/show/NCT05313529" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05313529</a>).</p></section><section id="s2-2"><h3 class="pmc_sec_title">Study population</h3>
<p>A total of 396 eligible participants will be consecutively enrolled from five clinical subcentres, including Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing First Hospital, Wuxi People’s Hospital, Changzhou Second People’s Hospital and Nanjing Jiangning Hospital. The complete list of participating study sites is maintained in the ‘Contacts/Locations’ section of the trial’s registration at ClinicalTrials.gov (ID: <a href="https://clinicaltrials.gov/ct2/show/NCT05313529" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05313529</a>). Participating centres were chosen based on the following essential criteria: (a) membership in Diabetes- Cognitive Dysfunction Consortium; (b) formal written agreements to ensure protocol adherence and compliance monitoring, supported by institutional ethical approvals and good clinical practice (GCP) certification; (c) tertiary hospitals with certified diabetes and neurology clinics, enabling comprehensive clinical and cognitive assessments; (d) multidisciplinary teams with documented research experience in the fields of endocrinology and cognitive health; (e) capacity to implement the required data collection and management systems for accurate data handling. To ensure adequate representativeness of each site, although a competitive enrolment approach is adopted, adjustments to the actual enrolment numbers from each subcentre will be made as necessary to maintain a relatively balanced distribution of participants across subcentres. Ideally, the final enrolment from any subcentre should be less than 50% of the total study cases.</p>
<p>The inclusion and exclusion criteria are presented in <a href="#B1" class="usa-link">box 1</a>. Notably, as a pragmatic trial aiming to reflect real-world clinical practice, the study intentionally omitted restrictions on diabetes duration and sleep conditions to preserve natural population heterogeneity and enhance generalisability. This inclusive approach allows for more robust evaluation of treatment effects across diverse patient characteristics while maintaining clinical relevance. The potential influence of these unconstrained variables will be addressed through rigorous sensitivity analyses and subgroup analyses.</p>
<section class="bt xbox font-sm" id="B1"><h4 class="obj_head">Box 1.  Inclusion and exclusion criteria for the trial.</h4>
<section id="sec9"><h5 class="pmc_sec_title">Inclusion criteria</h5>
<ol class="list" style="list-style-type:decimal">
<li><p>Participants aged ≥40 years and ≤75 years, of any gender.</p></li>
<li><p>Type 2 diabetes diagnosed according to the American Diabetes Association criteria (19).</p></li>
<li>
<p>MCI diagnosed according to the established criteria (17).</p>
<ol class="list" style="list-style-type:decimal">
<li><p>Cognitive concern from the patient or an informant or skilled clinicians.</p></li>
<li><p>Objective evidence of cognitive impairment: education-adjusted MoCA score ≤ 25 and ≥ 18; or ≥ 1.0 SD below the mean of age-specific and education-specific groups on any cognitive subdomain.</p></li>
<li><p>Preservation of independence in daily living abilities: Barthel Index score ≥ 60.</p></li>
<li><p>Absence of dementia.</p></li>
</ol>
</li>
<li><p>Treatment with a stable glucose lowering regimen of metformin monotherapy (≥ 1000 mg daily) or combination with sulfonylurea/glibenclamide/glycosidase inhibitor/basal insulin over the previous 3 months.</p></li>
<li><p>Glycosylated haemoglobin during screening between ≥ 7.0% and ≤ 10.0%.</p></li>
<li><p>BMI of ≥ 19 kg/m<sup>2</sup>.</p></li>
<li><p>Education duration of ≥ 6 years.</p></li>
<li><p>Right-handed participants.</p></li>
<li><p>Understanding of the research procedures and methods, potential benefits and risks of the trial and sign written informed consent.</p></li>
</ol></section><section id="sec10"><h5 class="pmc_sec_title">Exclusion criteria</h5>
<ol class="list" style="list-style-type:decimal">
<li><p>History of other dementia-related neurological diseases, depression within the past 2 years, developmental disorders, mania, depression, schizophrenia, etc.</p></li>
<li><p>Significant nasal sinusitis, nasal cavity and sinus polyps, cranial or nasopharyngeal tumours and other space-occupying lesions, congenital diseases and trauma of the nose, maxillofacial area and skull base that affect olfaction. Symptoms of upper respiratory tract infection on the day of MRI examination, including nasal congestion, rhinorrhoea, fever, etc.</p></li>
<li><p>Acute metabolic complications such as diabetic ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemic coma within the previous 6 months.</p></li>
<li><p>Severe organ dysfunction of heart, liver, kidneys and thyroid, including unstable angina, myocardial infarction or grade II and above cardiac insufficiency within 3 months before screening; eGFR by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula &lt;45 mL/min/1.73 m², alanine aminotransferase or aspartate aminotransferase greater than twice the upper limit of normal, hyperthyroidism or uncontrolled hypothyroidism.</p></li>
<li><p>History of medullary thyroid carcinoma, pancreatitis, multiple endocrine neoplasia syndrome type 2, recurrent urinary tract infections, severe gastrointestinal diseases or history of gastrointestinal surgery, history of malignant tumours.</p></li>
<li><p>With MRI contraindications, such as implanted metal prosthesis, claustrophobia, etc.</p></li>
<li><p>Female participants who are pregnant, lactating, breastfeeding or of childbearing age without effective contraception.</p></li>
<li><p>Participated in other clinical trials within the previous 6 months.</p></li>
<li><p>Known or suspected allergy to the study drugs.</p></li>
<li><p>Received treatment with GLP-1RAs, dual GLP-1R/GCGR agonist, SGLT-2 inhibitors or DPP4 inhibitors in the past 3 months.</p></li>
<li><p>Known history of drug or alcohol abuse within the past 6 months.</p></li>
</ol>
<section id="fn-group1" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="B1_FN1"><p>BMI, body mass index; DPP4, dipeptidyl peptidases 4; eGFR, estimated glomerular filtration rate; GCGR, glucagon receptor; GLP-1RAs, glucagon-like peptide-1 receptor agonists; SGLT-2, sodium-glucose cotransporter 2.</p></div></div></section></section></section><p>Patients will be selected by endocrinologists qualified in neuropsychological assessment during their routine follow-up consultation at the endocrinology department of each centre participating in the study. During the consultation, the endocrinologists will perform a brief cognitive screening for MCI with Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) and physical examination, document all concomitant treatments and verify inclusion and exclusion criteria. Details regarding prohibited concomitant medications are provided in the <a href="#SP1" class="usa-link">online supplemental file 1</a>. The endocrinologists will also inform patients and answer all their questions about the objective, the nature of constraints, foreseeable risks and benefits expected from the study. The doctor will precisely define the patients’ rights in relation to biomedical research. A copy of the patient information and consent form will then be given to the patients by the investigating doctor. After this information meeting, patients will be allowed a period of time to consider their decision concerning participation.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Study medication interventions</h3>
<p>In this trial, after discontinuing other antidiabetes medications besides metformin under guidance for 1 week, participants will be given another antidiabetes medication of liraglutide, empagliflozin or linagliptin with an intervention duration of 48 weeks in the core study. The participants who entered the extension study will continue on the same study medication to which they are randomised in the core study up to 28 weeks. For those patients who have used SGLT2 inhibitors or GLP-1 RAs or DPP4 inhibitors for less than half a year, a wash-out period of 3 months with gliclazide or basal insulin is additionally required.</p>
<section id="s2-3-1"><h4 class="pmc_sec_title">Tested drug 1: liraglutide</h4>
<p>Liraglutide (Victoza) is supplied as a disposable prefilled pen with the dosage of 18 mg for 3 mL per vial. It should be stored refrigerated at 4°C and has a shelf life of 36 months, with a reduced shelf life of 14 days after first use. Participants will initiate treatment with liraglutide at a starting dose of 0.6 mg administered via daily subcutaneous abdominal injection. The dose will be escalated in a stepwise manner over an 8-week titration period, with incremental increases to 1.2 mg and subsequently to the target maintenance dose of 1.8 mg, based on individual tolerance as assessed by the investigator. To optimise tolerability and minimise gastrointestinal adverse events, the protocol incorporates a flexible dose adjustment strategy that includes: (a) individualised adjustment of dose-escalation intervals within the 8-week period, (b) dose reduction to 1.2 mg as the maximum tolerated dose when necessary and (c) protocol-permitted treatment pauses of variable duration for managing persistent adverse events. All dose modifications will be implemented at the investigator’s discretion following comprehensive clinical evaluation of each participant’s response and tolerability profile.</p></section><section id="s2-3-2"><h4 class="pmc_sec_title">Tested drug 2: empagliflozin</h4>
<p>Empagliflozin tablets (Jardiance) are available in a specification of 10 mg per tablet and are taken orally. The tablets should be stored in a cool, dark place and kept sealed, with a shelf life of 24 months. The medication is manufactured by Boehringer Ingelheim Pharma GmbH &amp; Co. KG (Germany) and packaged by Boehringer Ingelheim Pharmaceuticals (Shanghai). Patients are instructed to take one 10 mg tablet daily, orally before breakfast.</p></section><section id="s2-3-3"><h4 class="pmc_sec_title">Tested drug 3: linagliptin</h4>
<p>Linagliptin tablets (Tradjenta) are available in a specification of 5 mg per tablet and are taken orally. The tablets should be stored in a cool, dark place and kept sealed, with a shelf life of 24 months. This medication is manufactured by Boehringer Ingelheim Pharmaceuticals. Patients are instructed to take one 5 mg tablet daily, orally before breakfast.</p></section><section id="s2-3-4"><h4 class="pmc_sec_title">Additional treatment criteria</h4>
<p>If glucose control does not meet standard during follow-up (fasting blood glucose ≥11.1 mmol/L more than twice or HbA1c≥8.5%), additional intervention with gliclazide (starting from 30 mg once daily and maximum dose not exceeding 120 mg) or basal insulin (insulin glargine injection) will be given. The actual glycaemic control target and additional treatment therapy will be determined by the investigators according to the individual conditions of participants.</p>
<p>All participants are trained in the daily use of self-monitoring strategies to encourage adherence to each assigned medication. In addition, they also receive lifestyle education on how to improve glycaemic management through diet and exercise. The consultation and advice are delivered through regular telephone interviews or follow-up visits.</p>
<p>Medication will be dispensed at week 0, 4, 8, 16, 24, 32, 40, 48, 56 and 64 by each trial centre.</p></section></section><section id="s2-4"><h3 class="pmc_sec_title">Study outcomes</h3>
<section id="s2-4-1"><h4 class="pmc_sec_title">Core study</h4>
<section id="s2-4-1-1"><h5 class="pmc_sec_title">Primary outcome</h5>
<p>The primary outcome measure of the trial is the efficacy of liraglutide, empagliflozin and linagliptin, administered as add-on therapy with the metformin monotherapy, in achieving MCI remission in individuals with T2D at 48 weeks of treatment.</p>
<p>MCI mitigation is defined by three criteria: an education-adjusted score of the MoCA ≥26, no cognitive deficits in any explored subdomain (with scores above the cut-off scores in all tests as detailed in <a href="#T1" class="usa-link">table 1</a>), including processing speed, executive function, immediate memory, visuospatial construction ability, language, attention and delayed memory, evaluated by Trail-Making Test, Stroop Color-Word Test and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), respectively, and preservation of ability to perform instrumental activity of daily living (IADL) with a Functional Activities Questionnaire (FAQ) score&lt;5.</p>
<section class="tw xbox font-sm" id="T1"><h6 class="obj_head">Table 1. The cut-off scores for various cognitive subdomains.</h6>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" valign="bottom" colspan="1">Scores/education</th>
<th colspan="6" valign="bottom" rowspan="1">Average (SD)</th>
<th colspan="6" valign="bottom" rowspan="1">Cognitive impairment</th>
</tr>
<tr>
<th colspan="2" valign="bottom" rowspan="1">Primary education<br>(6–9 years) (n=512)</th>
<th colspan="2" valign="bottom" rowspan="1">Secondary education<br>(9–12 years) (n=501)</th>
<th colspan="2" valign="bottom" rowspan="1">Higher education<br>(&gt;12 years) (n=627)</th>
<th colspan="2" valign="bottom" rowspan="1">Primary education<br>(6–9 years)</th>
<th colspan="2" valign="bottom" rowspan="1">Secondary education<br>(6–9 years)</th>
<th colspan="2" valign="bottom" rowspan="1">Higher education<br>(&gt;12 years)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Immediate memory</td>
<td colspan="2" align="left" valign="top" rowspan="1">71 (14)</td>
<td colspan="2" align="left" valign="top" rowspan="1">78 (15)</td>
<td colspan="2" align="left" valign="top" rowspan="1">85 (15)</td>
<td colspan="2" align="left" valign="top" rowspan="1">57</td>
<td colspan="2" align="left" valign="top" rowspan="1">63</td>
<td colspan="2" align="left" valign="top" rowspan="1">70</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Visuospatial construction</td>
<td colspan="2" align="left" valign="top" rowspan="1">99 (13)</td>
<td colspan="2" align="left" valign="top" rowspan="1">104 (13)</td>
<td colspan="2" align="left" valign="top" rowspan="1">109 (13)</td>
<td colspan="2" align="left" valign="top" rowspan="1">86</td>
<td colspan="2" align="left" valign="top" rowspan="1">91</td>
<td colspan="2" align="left" valign="top" rowspan="1">96</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Language</td>
<td colspan="2" align="left" valign="top" rowspan="1">96 (9)</td>
<td colspan="2" align="left" valign="top" rowspan="1">98 (9)</td>
<td colspan="2" align="left" valign="top" rowspan="1">100 (9)</td>
<td colspan="2" align="left" valign="top" rowspan="1">87</td>
<td colspan="2" align="left" valign="top" rowspan="1">89</td>
<td colspan="2" align="left" valign="top" rowspan="1">91</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Attention</td>
<td colspan="2" align="left" valign="top" rowspan="1">97 (11)</td>
<td colspan="2" align="left" valign="top" rowspan="1">104 (11)</td>
<td colspan="2" align="left" valign="top" rowspan="1">110 (11)</td>
<td colspan="2" align="left" valign="top" rowspan="1">86</td>
<td colspan="2" align="left" valign="top" rowspan="1">93</td>
<td colspan="2" align="left" valign="top" rowspan="1">99</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Delayed memory</td>
<td colspan="2" align="left" valign="top" rowspan="1">89 (14)</td>
<td colspan="2" align="left" valign="top" rowspan="1">93 (13)</td>
<td colspan="2" align="left" valign="top" rowspan="1">97 (13)</td>
<td colspan="2" align="left" valign="top" rowspan="1">75</td>
<td colspan="2" align="left" valign="top" rowspan="1">80</td>
<td colspan="2" align="left" valign="top" rowspan="1">84</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">RBANS total score</td>
<td colspan="2" align="left" valign="top" rowspan="1">87 (10)</td>
<td colspan="2" align="left" valign="top" rowspan="1">93 (11)</td>
<td colspan="2" align="left" valign="top" rowspan="1">100 (11)</td>
<td colspan="2" align="left" valign="top" rowspan="1">77</td>
<td colspan="2" align="left" valign="top" rowspan="1">82</td>
<td colspan="2" align="left" valign="top" rowspan="1">89</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
<td align="left" valign="top" rowspan="1" colspan="1">40–60</td>
<td align="left" valign="top" rowspan="1" colspan="1">60–80</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Processing speed</td>
<td align="left" valign="top" rowspan="1" colspan="1">144(65)</td>
<td align="left" valign="top" rowspan="1" colspan="1">192(74)</td>
<td align="left" valign="top" rowspan="1" colspan="1">126(59)</td>
<td align="left" valign="top" rowspan="1" colspan="1">158 (65)</td>
<td align="left" valign="top" rowspan="1" colspan="1">98(40)</td>
<td align="left" valign="top" rowspan="1" colspan="1">143(62)</td>
<td align="left" valign="top" rowspan="1" colspan="1">209</td>
<td align="left" valign="top" rowspan="1" colspan="1">266</td>
<td align="left" valign="top" rowspan="1" colspan="1">185</td>
<td align="left" valign="top" rowspan="1" colspan="1">223</td>
<td align="left" valign="top" rowspan="1" colspan="1">138</td>
<td align="left" valign="top" rowspan="1" colspan="1">205</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Executive function</td>
<td align="left" valign="top" rowspan="1" colspan="1">84(26)</td>
<td align="left" valign="top" rowspan="1" colspan="1">88(28)</td>
<td align="left" valign="top" rowspan="1" colspan="1">73(21)</td>
<td align="left" valign="top" rowspan="1" colspan="1">78(22)</td>
<td align="left" valign="top" rowspan="1" colspan="1">66(20)</td>
<td align="left" valign="top" rowspan="1" colspan="1">71(19)</td>
<td align="left" valign="top" rowspan="1" colspan="1">110</td>
<td align="left" valign="top" rowspan="1" colspan="1">116</td>
<td align="left" valign="top" rowspan="1" colspan="1">94</td>
<td align="left" valign="top" rowspan="1" colspan="1">100</td>
<td align="left" valign="top" rowspan="1" colspan="1">82</td>
<td align="left" valign="top" rowspan="1" colspan="1">90</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T1_FN1"><p>Immediate memory, visuospatial construction ability, language, attention and delayed memory are assessed by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Processing speed and executive function are evaluated with the following time tests: the Trail Making Test (parts A and B) and the Stroop Color-Word Test (parts I, II and III).</p></div>
<div class="fn" id="T1_FN2"><p>A longer time for completion (in s) represents worse processing speed and executive function. RBANS scores are standardised for age.</p></div>
</div></section></section><section id="s2-4-1-2"><h5 class="pmc_sec_title">Secondary outcomes</h5>
<p>Secondary outcome measures include changes over 48 weeks in the following areas, while comparing the postintervention differences of liraglutide versus linagliptin and empagliflozin versus linagliptin:</p>
<ul class="list" style="list-style-type:disc">
<li><p>Scores of general cognition, including MMSE, MoCA and total score of RBANS and various cognitive subdomains, including processing speed, executive function, immediate memory, visuospatial construction ability, language, attention and delayed memory.</p></li>
<li><p>Basic activities of daily living (BADL) and IDAL ability measured by the Barthel index and FAQ score, respectively.</p></li>
<li><p>MRI-derived normalised measures of total brain volume, cortical and nuclear volume, white matter hyperintensity volume, white matter integrity, glymphatic function, odour-induced brain activation and resting-state functional connectivity.</p></li>
<li><p>Olfactory function, comprised of olfactory threshold, odour identification and odour memory.</p></li>
<li>
<p>Metabolic parameters, which include the following indicators:</p>
<ul class="list" style="list-style-type:disc">
<li><p>Glucose metabolism indicators, including glycated haemoglobin (HbA1c), fasting and 2 hour postprandial plasma glucose, insulin and C-peptide, pancreatic islet function and insulin resistance indexes as calculated by the Homeostasis model assessment.</p></li>
<li><p>Lipid metabolism indicators, including lipid profile (triglyceride, total cholesterol, high-density and low-density lipoprotein-cholesterol), visceral and liver fat content.</p></li>
<li><p>Anthropometric indicators, including blood pressure, body weight, body mass index, waist circumference, hip circumference and body composition analysis.</p></li>
<li><p>Liver stiffness and hepatic fat attenuation confirmed by the FibroTouch system to assess the liver fibrosis and fatty liver levels.</p></li>
</ul>
</li>
</ul></section><section id="s2-4-1-3"><h5 class="pmc_sec_title">Exploratory outcomes</h5>
<ul class="list" style="list-style-type:disc"><li><p>The effects of liraglutide, empagliflozin and linagliptin on the 48-week change in blood-based biomarkers for Alzheimer disease-specific pathophysiology and neural injury.</p></li></ul></section></section></section><section id="s2-5"><h3 class="pmc_sec_title">Extension phase</h3>
<section id="s2-5-1"><h4 class="pmc_sec_title">Primary outcome</h4>
<p>The efficacy difference of liraglutide, empagliflozin and linagliptin treatment in achieving MCI remission at the end of the core study is maintained at 76 weeks of treatment.</p></section><section id="s2-5-2"><h4 class="pmc_sec_title">Secondary outcomes</h4>
<p>Secondary outcome measures of the extension phase remained the same as those of the core study and only the time points of evaluation are at 76 weeks of treatment.</p></section></section><section id="s2-6"><h3 class="pmc_sec_title">Study visits and follow-up</h3>
<p>The investigator will be responsible for obtaining written informed consent from the patients (<a href="#SP2" class="usa-link">online supplemental file 2</a>). The consent form must be signed before any clinical or paraclinical examination necessary for the study is performed. For patients agreeing to participate, the patient and the investigator will sign the consent form, on which they will clearly mark their full names. The various copies of the patient information and informed consent form will then be distributed as follows:</p>
<ul class="list" style="list-style-type:disc">
<li><p>A copy of the patient information and a signed informed consent form will be given to the patient.</p></li>
<li><p>The original will be kept by the investigator, in a safe place inaccessible to third parties.</p></li>
</ul>
<p>After provision of informed consent, visit 1 starts a 7-day screening period during which the trial inclusion and exclusion criteria are checked and basic demographics are collected (including from clinical examination, laboratory measurements, global cognition, BADL, subjective sleep assessment, anxiety and depression assessments). Eligible subjects are invited to the baseline visit (the introduction period continuing for 7 days), where all outcome measures (including laboratory examinations, genomic analysis, blood-based biomarkers, comprehensive cognitive assessments, IADL assessment, structural and functional MRI, olfactory function measurement, body composition analysis and liver ultrasound transient elastography) are assessed prior to the randomisation step. Then participants are randomised into the liraglutide, empagliflozin or linagliptin group and study drugs are dispensed. Visit 3 is conducted at 28 (week 4)±2 days after randomisation, with a particular focus on assessment of drug safety and adverse events. Further follow-ups are conducted at 56 (week 8)±3, 112 (week 16)±3, 168 (week 24)±3, 224 (week 32)±3, 280 (week 40)±3, 336 (week 48)±7 in the core study. Subjects who complete the core study will have the option to participate in the extension phase. The extension phase will continue for up to 28 weeks, and clinical and safety assessments will be conducted every 8 weeks. Vital signs (blood pressure, heart rate), anthropometrics (height, weight, waist/hip circumference) and peripheral blood glucose are measured at every visit. Metabolic assessments (HbA1c, lipid profiles) and organ function tests (liver, renal) are performed at baseline, weeks 24, 48 and 76, alongside cognitive screening (MoCA), body composition analysis (InBody 770) and liver ultrasound transient elastography. The remaining primary and secondary outcome measures, consisting of oral glucose and insulin tolerance test, comprehensive neuropsychological testing (MMSE, RBANS, Trail Making Test, Stroop Colour-Word Test), functional assessments (BADL, IADL), blood-based biomarkers, structural and functional MRI, as well as olfactory function measurements, are conducted at baseline, week 48 and week 76. The clinical assessments are conducted by a trained research nurse and a trained research doctor, when indicated. The neuropsychological assessments are administered and scored by the same certified examiner at each research site. Of note, all assessments are conducted by independent assessors who are blinded to treatment allocation. The trial design and schedule of assessments is shown in <a href="#F1" class="usa-link">figure 1</a> and <a href="#SP3" class="usa-link">online supplemental file 3</a>.</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">Figure 1.  The LIGHT-MCI trial design. BADL, basic activity of daily living; IADL, instrumental activity of daily living; MCI, mild cognitive impairment; MRI, Magnetic Resonance Imaging.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374654_bmjopen-15-8-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d260/12374654/91b0822e1ad2/bmjopen-15-8-g001.jpg" loading="lazy" height="393" width="740" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="s2-7"><h3 class="pmc_sec_title">Discontinuation of study intervention</h3>
<p>Study medication may be discontinued for a participant for the following reasons:</p>
<ul class="list" style="list-style-type:disc">
<li><p>By request of the participant or participant’s designee (eg, legal guardian)</p></li>
<li><p>Severe or recurrent hypoglycaemia, which is defined as episodes occurring more than twice per week.</p></li>
<li><p>Uncontrolled hyperglycaemia even with additional treatment (fasting capillary or venous blood glucose level &gt;13.3 mmol/L).</p></li>
<li><p>Development of protocol-defined contraindications.</p></li>
<li><p>Occurrence of serious adverse events, laboratory abnormalities and other drug-unrelated adverse events (including acute cardiovascular and cerebrovascular events, etc) during the treatment period.</p></li>
<li><p>Participation in other clinical trials involving an investigational medicinal product or enrolment in any other type of medical research judged not to be scientifically or medically compatible with this study</p></li>
<li><p>Poor compliance with the treatment plan or visit schedule.</p></li>
<li><p>The participant requires a prohibited concomitant therapeutic agent.</p></li>
<li><p>Women who are pregnant, planning to become pregnant or lactating.</p></li>
<li><p>Participation in the study needs to be stopped for medical, safety, regulatory or other reasons consistent with applicable laws, regulations and GCP.</p></li>
</ul></section><section id="s2-8"><h3 class="pmc_sec_title">Sample size determination</h3>
<p>This superiority trial is powered for two independent primary comparisons (liraglutide vs linagliptin and empagliflozin vs linagliptin), each tested at two-sided α=0.05 without multiplicity adjustment. Based on our pilot data, we assumed 48-week MCI remission rates of 50% (liraglutide) and 30% (empagliflozin). Previous studies of DPP4 inhibitors have shown a neutral effect on cognitive function, but the reversion rates from MCI to normal cognition are estimated to be approximately 10–15% in clinic-based studies, and therefore its MCI remission rate is assumed to be 15% in our study.<a href="#R22" class="usa-link" aria-describedby="R22"><sup>22 23</sup></a> These assumptions yielded absolute differences of 35% (liraglutide vs linagliptin) and 15% (empagliflozin vs linagliptin). Using PASS V.15.0 (NCSS, Kaysville, Utah, USA; <a href="http://www.ncss.com/software/pass" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ncss.com/software/pass</a>) with 80% power and 1:1:1 allocation, the required sample sizes were 25 per group for liraglutide and 118 per group for empagliflozin comparisons. To ensure adequate power for both prespecified tests, we selected the larger sample size (118 per group), ultimately enrolling 132 per arm (total n=396) after accounting for 10% attrition.</p></section><section id="s2-9"><h3 class="pmc_sec_title">Randomisation and blinding</h3>
<p>This trial adopts a block randomisation method with a block size of six, with each centre competing for enrolment. The randomisation list will be centrally generated by the statistician of the LIGHT-MCI trial platform before the start of the trial. This randomisation list and a document describing the randomisation procedure will be kept confidential by the LIGHT-MCI statistician who is not involved in participant screening or treatment. Participants meeting the eligibility criteria will be assigned a random number by a web-based system (JianDaoYun, Fanruan Software) and will be allocated to the ‘liraglutide’, ‘empagliflozin’, or ‘linagliptin’ group by randomisation in a 1:1:1 ratio after all baseline assessments are completed. When it is confirmed that the subjects are successfully enrolled, the researcher applies for the randomisation allocation process, fills in the date and subject label and the randomisation process manager matches the random number and returns it to the applicant to complete the single randomisation allocation process.</p>
<p>Given the inherent challenges of complete blinding due to differing drug administration routes (oral vs injectable), this study has implemented a rigorous evaluator blinding approach to uphold research integrity. The study involves four independent teams with strictly segregated workflows, including intervention, evaluation, statistical and monitoring teams. The intervention team is dedicated to participant enrolment and clinical management. The evaluation team conducts all participant assessments and collects anonymised data while remaining blinded to group allocation. All assessors underwent standardised blinding protocol training and worked in controlled environments free of treatment identifiers. The statistical team, unaware of study cohorts, performs data cleaning and verification according to standard procedures. Finally, the statistical team will lock the database once declared complete and accurate and will perform statistical analysis based on the pre-specified plan.</p>
<p>If accidental unblinding occurs, it is immediately documented (time, cause, personnel) and reported to the independent data and safety monitoring committee (IDSMC). The unblinded assessor is replaced, and affected data are flagged for sensitivity analysis. Preventive measures include enhanced staff training on blinding protocols, regular environmental audits and ongoing process monitoring by the study coordinator. All unblinding events and corrective actions will be transparently reported in the final publication. Statistical analyses will also include pre-unblinding and post-unblinding comparisons to assess potential outcome impacts.</p></section><section id="s2-10"><h3 class="pmc_sec_title">Data management</h3>
<p>Electronic data capture (EDC) system is used for data entry and management in this trial. The data management software used is Jiandaoyun, developed by Fanruan company. The software Jiandaoyun has been developed to meet the regulatory requirements. The software complies with the FDA requirements regarding IT systems used in clinical trials (‘Guidance for Computerised System Used in Clinical Trials’) as well as electronic signature (‘21CFR part 11’) and various international norms (CDISC/CDASH, ICH, GCP 2001/20/CE). Information extracted from participants’ medical records is anonymised, captured through an electronic case report form (eCRF), and diligently entered into the EDC system by trained data management personnel. The eCRF must be completed during or after each study visit. Access to the eCRF for data entry or review will require distinct individual access codes assigned uniquely to the site staff members who will be entering study data and those involved in study oversight who may review study data. Data are collected within the eCRF, to which the sponsor and sites monitors have exclusively ‘read only’ access. Rigorous electronic checks, source data verification and clinical monitoring protocols are implemented to guarantee the accuracy of data in comparison to original source documentation. The database must be closed in order to make the final analysis. The closure of the database is performed by the Jiandaoyun software.</p></section><section id="s2-11"><h3 class="pmc_sec_title">Methods for statistical analyses</h3>
<p>The intention-to-treat (ITT) population will serve as the primary population for all efficacy analyses. The ITT population consists of all randomised participants with available data at baseline analysed according to their allocated treatment group irrespective of whether treatment was administered or not. Additionally, the per-protocol (PP) population will also be conducted for supportive analysis. The PP population includes only those participants who completed the study according to the protocol and reached all primary endpoints without major deviations. Patients will be analysed according to the treatment they actually received. The As-treated (AT) population, which includes all eligible patients who started the study treatment (at least one dose), will be used for the safety analysis in this study.</p>
<p>Participant demographic characteristics and other baseline information will be summarised by treatment group. Categorical variables will be presented as frequencies (with percentages). Continuous variables will be reported as means (SD) or medians (IQR) for non-normality of distribution. For the primary outcome, the generalised estimating equation (GEE) regression models based on ITT population will be used with the Poisson family function and log link function, treating group variable as categorical with the control arm as the reference group, generating risk ratios and 95% CIs of the two experimental arms. For secondary and exploratory outcomes, the linear mixed-effects models on the ITT population will be conducted for continuous response variables. In the mixed-effects models, participant is assumed to be a random effect, and group, time and a treatment by time interaction term (which, if significant, will be indicative of efficacy) are assumed to be estimable fixed effects. Subgroup analyses will examine treatment effect heterogeneity according to baseline characteristics, including but not limited to age, sex, education and diabetes duration. Full details will be provided in the pre-specified statistical analysis plan.</p>
<p>For missing primary outcome data, we will conduct sensitivity analyses considering both best-case and worst-case scenarios. For missing secondary and exploratory outcome data, we will use mixed-effects models with maximum likelihood estimation, which provides valid inference under the missing-at-random assumption by incorporating all available longitudinal data. To further ensure robustness, we will conduct sensitivity analyses using multiple imputation by chained equations with 50 imputations, including baseline characteristics, observed outcome trajectories and treatment adherence as predictors.</p>
<p>Evaluations of safety will be performed on the AT population. The incidence of adverse events (including changes from baseline in physical examination), out-of-normal-range laboratory safety test variables and out-of-range vital signs, along with change from baseline in laboratory safety test variables and vital sign measurements, will be summarised by treatment group. The incidence of adverse events among the three groups will be analysed by χ<sup>2</sup> test.</p>
<p>Additional supportive analysis on a PP basis will be carried out to examine the conclusions’ robustness to different assumptions about departures from the randomisation procedure. A full, detailed statistical analysis plan will be finalised before database lock and treatment unblinding. No formal interim analysis has been planned for the trial. All analyses will be performed using SAS V.9.4 or higher (SAS Institute, Cary, North Carolina). A p value of &lt;0.05 (two-tailed) will be considered statistically significant.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Trial oversight</h2>
<section id="s3-1"><h3 class="pmc_sec_title">Data monitoring and auditing</h3>
<p>The chief investigator holds overall responsibility for the conduct of the trial, while the trial management group is responsible for the day-to-day oversight of the trial.</p>
<p>The trial scientific committee, comprised of independent clinicians and an independent statistician, acts as the oversight body for the trial on behalf of the sponsor. This committee will take responsibility for monitoring and guiding overall progress, scientific standards and operational delivery, ensuring the protection of participants’ rights and safety throughout the trial. The scientific committee will meet at least four times a year to monitor subject accrual and to monitor compliance with the protocol at individual study sites. The scientific committee will be blinded to subject treatment assignments during the trial.</p>
<p>An IDSMC will be established and composed of at least three members: an endocrinologist, a statistician and a vigilance specialist, independent from the study scientific team. The objective of the IDSMC is to review safety and progress toward completion of study. The IDSMC charter, outlining membership, terms of reference, roles, responsibilities, authority, decision-making processes and interactions (including the timing of meetings, methods of providing information to and from the committee, frequency and format of meetings, statistical issues and relationships with other committees) for this trial is established, reviewed and approved prior to the inaugural committee meeting. Adverse events and serious adverse events will be reviewed by IDSMC to determine the cause of these events and take any necessary measures to ensure participant safety. Following each meeting, the IDSMC will provide the study team with information concerning findings for the trial as a whole related to cumulative toxicities observed and any relevant recommendations related to continuing, changing or terminating the trial. The IDSMC will provide a summary of the committee findings to the sponsor and coordinating investigator.</p></section><section id="s3-2"><h3 class="pmc_sec_title">Harms</h3>
<p>Safety and tolerability assessments will encompass comprehensive monitoring and recording all adverse events and serious adverse events, alongside routine checks of vital signs, physical examinations and laboratory evaluations. Adverse events are any untoward medical occurrence in patients or clinical investigation subjects administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. The investigational drug-related adverse events in the trial mainly include gastrointestinal symptoms such as vomiting, nausea, diarrhoea, bloating and abdominal pain, liver or kidney damage, urogenital infection, rash, headache, hypoglycaemia, diabetic ketoacidosis, dehydration and electrolyte imbalances.</p>
<p>Serious adverse events are defined as undesirable signs or medical conditions that are fatal or life-threatening, necessitate hospitalisation, result in persistent or significant disability/incapacity or are otherwise medically significant.</p>
<p>All adverse events and serious adverse events, whether reported by the participant, discovered during questioning, directly observed or detected by physical examination, laboratory test or other means, will be recorded in the participant’s medical record and on the appropriate study-specific case report forms. Each adverse event will be detailed concerning its duration, intensity, actions taken and outcomes. The investigator must evaluate the causal relationship between the study drugs and the adverse event. If the adverse event is not related to the study, the investigator must determine the alternative causality (diabetes, concomitant treatment, other disease, etc). To ensure participants’ safety, all serious adverse events will be promptly reported to the chief investigator, data monitoring and ethics committee within 24 hours and processed in a timely manner. Any serious adverse event that is ongoing when the subject completes or discontinues the study will be followed by the investigator until the event has resolved, stabilised or returned to baseline status.</p></section><section id="s3-3"><h3 class="pmc_sec_title">Ethics and dissemination</h3>
<p>The LIGHT-MCI trial has obtained ethical approvals from the institutional review boards of all participating centres, which include Drum Tower Hospital Affiliated to Nanjing University Medical School (2022-092-02), Nanjing First Hospital (KY20230210-01-KS-01), Wuxi People’s Hospital (2024-IIT-04), Changzhou Second People’s Hospital ((2024)KY07-01) and Nanjing Jiangning Hospital (2024-03-009-K01). All approvals were granted in full compliance with the principles of the Declaration of Helsinki and the International Conference on Harmonisation for GCP (ICH GCP E6). This trial is registered on ClinicalTrials.gov (<a href="https://clinicaltrials.gov/ct2/show/NCT05313529" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT 05313529</a>). All participants provide written informed consent for their participation and biological collection, and clinical trial insurance is purchased to offer compensation for any physical harm, health impairment or death that may occur during the trial. Any significant modifications to the study protocol initiated by the coordinating investigator must receive prior approval from the ethics committee before implementation. Should such substantial amendments be required, all relevant documentation, particularly the informed consent forms, will be promptly updated to reflect these changes.</p>
<p>The results of the core study are expected in 2026 and will be disseminated through publication in peer-reviewed medical journals, as well as presentations at relevant national and international conferences. Data arising from and samples collected during the trial will not be made publicly available but will be available for collaborative sharing, after the main results of the trial have been published, and upon application to and approval by the trial management group.</p></section><section id="s3-4"><h3 class="pmc_sec_title">Patient and public involvement</h3>
<p>No patient is involved. The development of the research question and outcome measures was informed by clinical observations and existing literature on cognitive benefits of certain antidiabetic agents. Patients were not directly involved in the study’s design, recruitment or conduct. The study design relied on previous protocols and expert consultations. Results will be shared with participants through follow-up appointments. The intervention’s burden was not formally assessed by patients, but the protocol aimed to minimize the burden based on prior studies. There are no patient advisers to thank in the contributorship statement or acknowledgements.</p></section><section id="s3-5"><h3 class="pmc_sec_title">Trial status</h3>
<p>The current protocol document is V.4.0, dated 1 August 2024. Enrolment in the LIGHT-MCI trial commenced in November 2022. Currently, enrolment is ongoing with 300 participants enrolled as of 1 October 2024 and is projected to conclude in January 2025. The last participant is expected to reach the primary endpoint of the core study in January 2026. The extension phase will continue until the summer of 2026. No interim analyses are planned, thus results on outcomes will not inform decisions to stop the study. Any serious adverse events, however, will be reviewed, and if there is any indication that these are linked to the intervention, consideration will be given to discontinuing the trial on the advice of the trial sponsor and participating clinical services. Failure to recruit could also be a reason to stop the trial.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<p>The LIGHT-MCI trial is a prospective, multicentre, randomised, parallel-controlled, superiority clinical trial with a core phase and an extension phase designed to evaluate the cognitive benefits of liraglutide, empagliflozin and linagliptin in T2D patients with MCI. To our knowledge, there is no other randomised clinical trials underway that could address the question.</p>
<p>Diabetes is an established risk factor for cognitive dysfunction, while intensive glycaemic control did not show long-term beneficial effects on cognitive outcomes in the Action to Control Cardiovascular Risk in Diabetes study.<a href="#R24" class="usa-link" aria-describedby="R24"><sup>24 25</sup></a> Notably, in recent years, specific antidiabetic agents have exhibited promising benefits on cardiovascular and renal outcomes in addition to safe and effective glucose‐lowering effects.<a href="#R26" class="usa-link" aria-describedby="R26"><sup>26</sup></a>,<a href="#R29" class="usa-link" aria-describedby="R29"><sup>29</sup></a> Thus, increasing attention has been paid to determining whether there is a protective effect of novel antidiabetic agents on cognitive function. Preliminary evidence has shown that certain novel antidiabetic agents, such as GLP-1RAs and SGLT2 inhibitors, significantly improved cognitive function in subjects with diabetes, serving as potentially promising candidates against cognitive dysfunction.<a href="#R30" class="usa-link" aria-describedby="R30"><sup>30</sup></a>,<a href="#R32" class="usa-link" aria-describedby="R32"><sup>32</sup></a> However, there is still a lack of prospective head-to-head randomised controlled trials to establish the cognitive efficacy of various antidiabetic medications for cognitive dysfunction in diabetes.</p>
<p>Notably, the LIGHT-MCI trial is the first head-to-head active-controlled outcome study that directly compares three prevalent second-line antidiabetic therapies: liraglutide, empagliflozin and linagliptin. The trial uniquely sets MCI remission as the primary endpoint. Linagliptin, serving as an ideal active control, is driven by two pivotal considerations. On the one hand, this study focuses on individuals with T2D and MCI who have inadequate glycaemic control on metformin monotherapy. In line with current international guidelines, these patients typically necessitate dual-combination therapy to achieve glycaemic targets while minimising the risk of hypoglycaemia.<a href="#R8" class="usa-link" aria-describedby="R8"><sup>8</sup></a> On the other hand, evidence from the CARMELINA and CAROLINA-COGNITION trials has conclusively demonstrated that linagliptin does not influence cognitive function.<a href="#R19" class="usa-link" aria-describedby="R19"><sup>19 20</sup></a> This allows us to evaluate the potential cognitive benefits of GLP-1 RAs and SGLT-2 inhibitors against a control arm with established glycaemic efficacy but neutral neurological impact. Given that longitudinal studies have noted that approximately 10–15% of individuals initially classified with MCI may revert to normal cognition on subsequent assessments, the MCI remission rates for the linagliptin group in this study are assumed to be 15%.<a href="#R22" class="usa-link" aria-describedby="R22"><sup>22 23</sup></a></p>
<p>Impairment of the olfactory neural circuit is associated with the risk of MCI and accelerated progression from MCI to dementia, and has been considered an early indicator of cognitive decline in T2D.<a href="#R33" class="usa-link" aria-describedby="R33"><sup>33</sup></a>,<a href="#R35" class="usa-link" aria-describedby="R35"><sup>35</sup></a> Our previous single-arm study found that GLP-1 RAs treatment for 3 months significantly improved general cognition, olfactory function and increased olfactory brain activation in obese patients with T2D.<a href="#R11" class="usa-link" aria-describedby="R11"><sup>11</sup></a> Furthermore, a 16-week head-to-head randomised parallel trial demonstrated that GLP-1 RA treatment markedly enhanced the impaired odour-induced left hippocampal activation and improved certain cognitive subdomains, whereas dapagliflozin and acarbose did not. And such cognitive function improvements could be partly ascribed to the direct effects of GLP-1 RAs on olfactory brain activation, as well as to the metabolic ameliorations.<a href="#R21" class="usa-link" aria-describedby="R21"><sup>21</sup></a> Therefore, the key secondary objectives of LIGHT-MCI investigate the changes in various brain morphometric measures, olfactory brain activation and resting-state functional connectivity, olfactory function, as well as metabolic parameters of the three parallel groups from baseline to 48 weeks and 76 weeks, aiming to shed light on potential mechanisms underlying the cognitive benefits of certain antidiabetic agents.</p>
<p>In conclusion, the LIGHT-MCI trial is poised to provide groundbreaking insights into the comparative effects of various antidiabetic drug classes on achieving MCI remission in patients with T2D. The findings are expected to bridge critical evidence gaps in antidiabetic drug selection for T2D patients with cognitive dysfunction, guiding clinical decision-making and informing future clinical practice guidelines.</p></section><section id="s5"><h2 class="pmc_sec_title">Supplementary material</h2>
<section class="sm xbox font-sm" id="SP1"><div class="caption p"><span>online supplemental file 1</span></div>
<div class="media p" id="d67e1029">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s001.pdf</a><sup> (157.7KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section><section class="sm xbox font-sm" id="SP2"><div class="caption p"><span>online supplemental file 2</span></div>
<div class="media p" id="d67e1034">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s002.pdf</a><sup> (383.5KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section><section class="sm xbox font-sm" id="SP3"><div class="caption p"><span>online supplemental file 3</span></div>
<div class="media p" id="d67e1039">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s003.pdf</a><sup> (219.4KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors thank all volunteers for their participation in this study as well as all the involved clinicians, nurses and technicians from the Drum Tower Hospital Affiliated to Nanjing University Medical School and other subcentres for dedicating their time and efforts to this study.</p></section><section id="notes1"><p>The funding bodies have no role in the design of the study, collection, analysis and interpretation of data, writing of the manuscript, or publication.</p></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn6"><p><strong>Funding:</strong> This academic study was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2024ZD0523200 and 2023ZD0507903), the National Natural Science Foundation of China Grant Awards (82470866, 82470865, 82450002, 82030026, and 82270883), the National Chinese-Western Medicine Clinical Collaboration Project for Major Difficult Diseases, the Key Research and Development Program of Jiangsu Province of China (BE2022666 and BE2023774), the Natural Science Foundation of Jiangsu Province of China (BK20240116 and BK20241721), the Fundamental Research Funds for the Central Universities (14380546) and Fundings for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-ZD-03, 2022-LCYJ-PY-02).</p></div>
<div class="fn p" id="fn7"><p>Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online (<a href="https://doi.org/10.1136/bmjopen-2024-095382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1136/bmjopen-2024-095382</a>).</p></div>
<div class="fn p" id="fn8"><p><strong>Provenance and peer review:</strong> Not commissioned; externally peer reviewed.</p></div>
<div class="fn p" id="fn9"><p><strong>Patient consent for publication:</strong> Not applicable.</p></div>
<div class="fn p" id="fn10"><p><strong>Patient and public involvement:</strong> Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>International Diabetes Federation  . Diabetes Atlas. 10th. 2021. <a href="https://www.diabetesatlas.org/atlas/tenth-edition" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.diabetesatlas.org/atlas/tenth-edition</a> edn. Available.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Diabetes%20Atlas&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Feigin VL, Nichols E, Alam T, et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459–80. doi: 10.1016/S1474-4422(18)30499-X.</cite> [<a href="https://doi.org/10.1016/S1474-4422(18)30499-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6459001/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30879893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Global,%20regional,%20and%20national%20burden%20of%20neurological%20disorders,%201990%E2%80%932016:%20a%20systematic%20analysis%20for%20the%20Global%20Burden%20of%20Disease%20Study%202016&amp;author=VL%20Feigin&amp;author=E%20Nichols&amp;author=T%20Alam&amp;volume=18&amp;publication_year=2019&amp;pages=459-80&amp;pmid=30879893&amp;doi=10.1016/S1474-4422(18)30499-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>World Health Organization  . Geneva, Switzerland: 2021.  [15-Mar-2023]. Fact sheets of dementia (eb/ol)<a href="https://www.%20who.%20int/news%20room/%20fact%20sheets/detail/dementia" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www. who. int/news room/ fact sheets/detail/dementia</a> Available. accessed.</cite> [<a href="https://scholar.google.com/scholar_lookup?World%20Health%20Organization%20.%20Geneva,%20Switzerland:%202021.%20%5B15-Mar-2023%5D.%20Fact%20sheets%20of%20dementia%20(eb/ol)https://www.%20who.%20int/news%20room/%20fact%20sheets/detail/dementia%20Available.%20accessed." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>Biessels GJ, Strachan MWJ, Visseren FLJ, et al.  Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2:246–55. doi: 10.1016/S2213-8587(13)70088-3.</cite> [<a href="https://doi.org/10.1016/S2213-8587(13)70088-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24622755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Diabetes%20Endocrinol&amp;title=Dementia%20and%20cognitive%20decline%20in%20type%202%20diabetes%20and%20prediabetic%20stages:%20towards%20targeted%20interventions&amp;author=GJ%20Biessels&amp;author=MWJ%20Strachan&amp;author=FLJ%20Visseren&amp;volume=2&amp;publication_year=2014&amp;pages=246-55&amp;pmid=24622755&amp;doi=10.1016/S2213-8587(13)70088-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Livingston G, Huntley J, Sommerlad A, et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396:413–46. doi: 10.1016/S0140-6736(20)30367-6.</cite> [<a href="https://doi.org/10.1016/S0140-6736(20)30367-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7392084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32738937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Dementia%20prevention,%20intervention,%20and%20care:%202020%20report%20of%20the%20Lancet%20Commission&amp;author=G%20Livingston&amp;author=J%20Huntley&amp;author=A%20Sommerlad&amp;volume=396&amp;publication_year=2020&amp;pages=413-46&amp;pmid=32738937&amp;doi=10.1016/S0140-6736(20)30367-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Petersen RC, Lopez O, Armstrong MJ, et al.  Practice guideline update summary: Mild cognitive impairment [RETIRED]: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology (ECronicon) 2018;90:126–35. doi: 10.1212/WNL.0000000000004826.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000004826" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5772157/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29282327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20(ECronicon)&amp;title=Practice%20guideline%20update%20summary:%20Mild%20cognitive%20impairment%20%5BRETIRED%5D:%20Report%20of%20the%20Guideline%20Development,%20Dissemination,%20and%20Implementation%20Subcommittee%20of%20the%20American%20Academy%20of%20Neurology&amp;author=RC%20Petersen&amp;author=O%20Lopez&amp;author=MJ%20Armstrong&amp;volume=90&amp;publication_year=2018&amp;pages=126-35&amp;pmid=29282327&amp;doi=10.1212/WNL.0000000000004826&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Kantarci K, Weigand SD, Przybelski SA, et al.  Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology (ECronicon) 2009;72:1519–25. doi: 10.1212/WNL.0b013e3181a2e864.</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3181a2e864" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2843530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19398707/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20(ECronicon)&amp;title=Risk%20of%20dementia%20in%20MCI:%20combined%20effect%20of%20cerebrovascular%20disease,%20volumetric%20MRI,%20and%201H%20MRS&amp;author=K%20Kantarci&amp;author=SD%20Weigand&amp;author=SA%20Przybelski&amp;volume=72&amp;publication_year=2009&amp;pages=1519-25&amp;pmid=19398707&amp;doi=10.1212/WNL.0b013e3181a2e864&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>American Diabetes Association Professional Practice Committee  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45:S17–38. doi: 10.2337/dc22-S002.</cite> [<a href="https://doi.org/10.2337/dc22-S002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34964875/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=2.%20Classification%20and%20Diagnosis%20of%20Diabetes:%20Standards%20of%20Medical%20Care%20in%20Diabetes%E2%80%942022&amp;volume=45&amp;publication_year=2022&amp;pages=S17-38&amp;pmid=34964875&amp;doi=10.2337/dc22-S002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Meng L, Li X-Y, Shen L, et al.  Type 2 Diabetes Mellitus Drugs for Alzheimer’s Disease: Current Evidence and Therapeutic Opportunities. Trends Mol Med. 2020;26:597–614. doi: 10.1016/j.molmed.2020.02.002.</cite> [<a href="https://doi.org/10.1016/j.molmed.2020.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32470386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20Mol%20Med&amp;title=Type%202%20Diabetes%20Mellitus%20Drugs%20for%20Alzheimer%E2%80%99s%20Disease:%20Current%20Evidence%20and%20Therapeutic%20Opportunities&amp;author=L%20Meng&amp;author=X-Y%20Li&amp;author=L%20Shen&amp;volume=26&amp;publication_year=2020&amp;pages=597-614&amp;pmid=32470386&amp;doi=10.1016/j.molmed.2020.02.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Boccardi V, Murasecco I, Mecocci P. Diabetes drugs in the fight against Alzheimer’s disease. Ageing Res Rev. 2019;54:100936. doi: 10.1016/j.arr.2019.100936.</cite> [<a href="https://doi.org/10.1016/j.arr.2019.100936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31330313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ageing%20Res%20Rev&amp;title=Diabetes%20drugs%20in%20the%20fight%20against%20Alzheimer%E2%80%99s%20disease&amp;author=V%20Boccardi&amp;author=I%20Murasecco&amp;author=P%20Mecocci&amp;volume=54&amp;publication_year=2019&amp;pages=100936&amp;pmid=31330313&amp;doi=10.1016/j.arr.2019.100936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Zhang Z, Zhang B, Wang X, et al.  Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies. Diabetes Care. 2019;42:1274–83. doi: 10.2337/dc18-2584.</cite> [<a href="https://doi.org/10.2337/dc18-2584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31221697/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Olfactory%20Dysfunction%20Mediates%20Adiposity%20in%20Cognitive%20Impairment%20of%20Type%202%20Diabetes:%20Insights%20From%20Clinical%20and%20Functional%20Neuroimaging%20Studies&amp;author=Z%20Zhang&amp;author=B%20Zhang&amp;author=X%20Wang&amp;volume=42&amp;publication_year=2019&amp;pages=1274-83&amp;pmid=31221697&amp;doi=10.2337/dc18-2584&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Li Q, Jia M, Yan Z, et al.  Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway. J Am Heart Assoc. 2021;10:e020734.  doi: 10.1161/JAHA.120.020734.</cite> [<a href="https://doi.org/10.1161/JAHA.120.020734" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8483500/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34250817/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Heart%20Assoc&amp;title=Activation%20of%20Glucagon-Like%20Peptide-1%20Receptor%20Ameliorates%20Cognitive%20Decline%20in%20Type%202%20Diabetes%20Mellitus%20Through%20a%20Metabolism-Independent%20Pathway&amp;author=Q%20Li&amp;author=M%20Jia&amp;author=Z%20Yan&amp;volume=10&amp;publication_year=2021&amp;pages=e020734&amp;pmid=34250817&amp;doi=10.1161/JAHA.120.020734&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Cukierman-Yaffe T, Gerstein HC, Colhoun HM, et al.  Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial. Lancet Neurol. 2020;19:582–90. doi: 10.1016/S1474-4422(20)30173-3.</cite> [<a href="https://doi.org/10.1016/S1474-4422(20)30173-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32562683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Effect%20of%20dulaglutide%20on%20cognitive%20impairment%20in%20type%202%20diabetes:%20an%20exploratory%20analysis%20of%20the%20REWIND%20trial&amp;author=T%20Cukierman-Yaffe&amp;author=HC%20Gerstein&amp;author=HM%20Colhoun&amp;volume=19&amp;publication_year=2020&amp;pages=582-90&amp;pmid=32562683&amp;doi=10.1016/S1474-4422(20)30173-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Vadini F, Simeone PG, Boccatonda A, et al.  Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study. Int J Obes (Lond) 2020;44:1254–63. doi: 10.1038/s41366-020-0535-5.</cite> [<a href="https://doi.org/10.1038/s41366-020-0535-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31965072/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Obes%20(Lond)&amp;title=Liraglutide%20improves%20memory%20in%20obese%20patients%20with%20prediabetes%20or%20early%20type%202%20diabetes:%20a%20randomized,%20controlled%20study&amp;author=F%20Vadini&amp;author=PG%20Simeone&amp;author=A%20Boccatonda&amp;volume=44&amp;publication_year=2020&amp;pages=1254-63&amp;pmid=31965072&amp;doi=10.1038/s41366-020-0535-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Wu C-Y, Iskander C, Wang C, et al.  Association of Sodium-Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study. Diabetes Care. 2023;46:297–304. doi: 10.2337/dc22-1705.</cite> [<a href="https://doi.org/10.2337/dc22-1705" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36508692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Association%20of%20Sodium-Glucose%20Cotransporter%202%20Inhibitors%20With%20Time%20to%20Dementia:%20A%20Population-Based%20Cohort%20Study&amp;author=C-Y%20Wu&amp;author=C%20Iskander&amp;author=C%20Wang&amp;volume=46&amp;publication_year=2023&amp;pages=297-304&amp;pmid=36508692&amp;doi=10.2337/dc22-1705&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Youn YJ, Kim S, Jeong H-J, et al.  Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis. Front Neuroendocrinol. 2024;73:101131. doi: 10.1016/j.yfrne.2024.101131.</cite> [<a href="https://doi.org/10.1016/j.yfrne.2024.101131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38367940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Neuroendocrinol&amp;title=Sodium-glucose%20cotransporter-2%20inhibitors%20and%20their%20potential%20role%20in%20dementia%20onset%20and%20cognitive%20function%20in%20patients%20with%20diabetes%20mellitus:%20a%20systematic%20review%20and%20meta-analysis&amp;author=YJ%20Youn&amp;author=S%20Kim&amp;author=H-J%20Jeong&amp;volume=73&amp;publication_year=2024&amp;pages=101131&amp;pmid=38367940&amp;doi=10.1016/j.yfrne.2024.101131&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Kim HK, Biessels GJ, Yu MH, et al.  SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes. Neurology (ECronicon) 2024;103:e209805.  doi: 10.1212/WNL.0000000000209805.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000209805" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39292986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20(ECronicon)&amp;title=SGLT2%20Inhibitor%20Use%20and%20Risk%20of%20Dementia%20and%20Parkinson%20Disease%20Among%20Patients%20With%20Type%202%20Diabetes&amp;author=HK%20Kim&amp;author=GJ%20Biessels&amp;author=MH%20Yu&amp;volume=103&amp;publication_year=2024&amp;pages=e209805&amp;pmid=39292986&amp;doi=10.1212/WNL.0000000000209805&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Shin A, Koo BK, Lee JY, et al.  Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study. BMJ. 2024;386:e079475.  doi: 10.1136/bmj-2024-079475.</cite> [<a href="https://doi.org/10.1136/bmj-2024-079475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11350613/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39197881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Risk%20of%20dementia%20after%20initiation%20of%20sodium-glucose%20cotransporter-2%20inhibitors%20versus%20dipeptidyl%20peptidase-4%20inhibitors%20in%20adults%20aged%2040-69%20years%20with%20type%202%20diabetes:%20population%20based%20cohort%20study&amp;author=A%20Shin&amp;author=BK%20Koo&amp;author=JY%20Lee&amp;volume=386&amp;publication_year=2024&amp;pages=e079475&amp;pmid=39197881&amp;doi=10.1136/bmj-2024-079475&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Biessels GJ, Verhagen C, Janssen J, et al.  Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial. Diabetes Care. 2019;42:1930–8. doi: 10.2337/dc19-0783.</cite> [<a href="https://doi.org/10.2337/dc19-0783" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31399442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Effect%20of%20Linagliptin%20on%20Cognitive%20Performance%20in%20Patients%20With%20Type%202%20Diabetes%20and%20Cardiorenal%20Comorbidities:%20The%20CARMELINA%20Randomized%20Trial&amp;author=GJ%20Biessels&amp;author=C%20Verhagen&amp;author=J%20Janssen&amp;volume=42&amp;publication_year=2019&amp;pages=1930-8&amp;pmid=31399442&amp;doi=10.2337/dc19-0783&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Biessels GJ, Verhagen C, Janssen J, et al.  Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study. Diabetologia. 2021;64:1235–45. doi: 10.1007/s00125-021-05393-8.</cite> [<a href="https://doi.org/10.1007/s00125-021-05393-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8099814/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33559704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=Effects%20of%20linagliptin%20vs%20glimepiride%20on%20cognitive%20performance%20in%20type%202%20diabetes:%20results%20of%20the%20randomised%20double-blind,%20active-controlled%20CAROLINA-COGNITION%20study&amp;author=GJ%20Biessels&amp;author=C%20Verhagen&amp;author=J%20Janssen&amp;volume=64&amp;publication_year=2021&amp;pages=1235-45&amp;pmid=33559704&amp;doi=10.1007/s00125-021-05393-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Cheng H, Zhang Z, Zhang B, et al.  Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but Not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study. Diabetes Care. 2022;45:1201–10. doi: 10.2337/dc21-2064.</cite> [<a href="https://doi.org/10.2337/dc21-2064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35263425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Enhancement%20of%20Impaired%20Olfactory%20Neural%20Activation%20and%20Cognitive%20Capacity%20by%20Liraglutide,%20but%20Not%20Dapagliflozin%20or%20Acarbose,%20in%20Patients%20With%20Type%202%20Diabetes:%20A%2016-Week%20Randomized%20Parallel%20Comparative%20Study&amp;author=H%20Cheng&amp;author=Z%20Zhang&amp;author=B%20Zhang&amp;volume=45&amp;publication_year=2022&amp;pages=1201-10&amp;pmid=35263425&amp;doi=10.2337/dc21-2064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Malek-Ahmadi M. Reversion From Mild Cognitive Impairment to Normal Cognition: A Meta-Analysis. Alzheimer Dis Assoc Disord. 2016;30:324–30. doi: 10.1097/WAD.0000000000000145.</cite> [<a href="https://doi.org/10.1097/WAD.0000000000000145" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26908276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Alzheimer%20Dis%20Assoc%20Disord&amp;title=Reversion%20From%20Mild%20Cognitive%20Impairment%20to%20Normal%20Cognition:%20A%20Meta-Analysis&amp;author=M%20Malek-Ahmadi&amp;volume=30&amp;publication_year=2016&amp;pages=324-30&amp;pmid=26908276&amp;doi=10.1097/WAD.0000000000000145&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Canevelli M, Grande G, Lacorte E, et al.  Spontaneous Reversion of Mild Cognitive Impairment to Normal Cognition: A Systematic Review of Literature and Meta-Analysis. J Am Med Dir Assoc. 2016;17:943–8. doi: 10.1016/j.jamda.2016.06.020.</cite> [<a href="https://doi.org/10.1016/j.jamda.2016.06.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27502450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Med%20Dir%20Assoc&amp;title=Spontaneous%20Reversion%20of%20Mild%20Cognitive%20Impairment%20to%20Normal%20Cognition:%20A%20Systematic%20Review%20of%20Literature%20and%20Meta-Analysis&amp;author=M%20Canevelli&amp;author=G%20Grande&amp;author=E%20Lacorte&amp;volume=17&amp;publication_year=2016&amp;pages=943-8&amp;pmid=27502450&amp;doi=10.1016/j.jamda.2016.06.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Launer LJ, Miller ME, Williamson JD, et al.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77. doi: 10.1016/S1474-4422(11)70188-0.</cite> [<a href="https://doi.org/10.1016/S1474-4422(11)70188-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3333485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21958949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Neurol&amp;title=Effects%20of%20intensive%20glucose%20lowering%20on%20brain%20structure%20and%20function%20in%20people%20with%20type%202%20diabetes%20(ACCORD%20MIND):%20a%20randomised%20open-label%20substudy&amp;author=LJ%20Launer&amp;author=ME%20Miller&amp;author=JD%20Williamson&amp;volume=10&amp;publication_year=2011&amp;pages=969-77&amp;pmid=21958949&amp;doi=10.1016/S1474-4422(11)70188-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Murray AM, Hsu F-C, Williamson JD, et al.  ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial. Diabetologia. 2017;60:69–80. doi: 10.1007/s00125-016-4118-x.</cite> [<a href="https://doi.org/10.1007/s00125-016-4118-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5633725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27766347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetologia&amp;title=ACCORDION%20MIND:%20results%20of%20the%20observational%20extension%20of%20the%20ACCORD%20MIND%20randomised%20trial&amp;author=AM%20Murray&amp;author=F-C%20Hsu&amp;author=JD%20Williamson&amp;volume=60&amp;publication_year=2017&amp;pages=69-80&amp;pmid=27766347&amp;doi=10.1007/s00125-016-4118-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al.  Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020;383:1436–46. doi: 10.1056/NEJMoa2024816.</cite> [<a href="https://doi.org/10.1056/NEJMoa2024816" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32970396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Dapagliflozin%20in%20Patients%20with%20Chronic%20Kidney%20Disease&amp;author=HJL%20Heerspink&amp;author=BV%20Stef%C3%A1nsson&amp;author=R%20Correa-Rotter&amp;volume=383&amp;publication_year=2020&amp;pages=1436-46&amp;pmid=32970396&amp;doi=10.1056/NEJMoa2024816&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>McMurray JJV, Solomon SD, Inzucchi SE, et al.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381:1995–2008. doi: 10.1056/NEJMoa1911303.</cite> [<a href="https://doi.org/10.1056/NEJMoa1911303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31535829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Dapagliflozin%20in%20Patients%20with%20Heart%20Failure%20and%20Reduced%20Ejection%20Fraction&amp;author=JJV%20McMurray&amp;author=SD%20Solomon&amp;author=SE%20Inzucchi&amp;volume=381&amp;publication_year=2019&amp;pages=1995-2008&amp;pmid=31535829&amp;doi=10.1056/NEJMoa1911303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al.  Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. 2023;389:1069–84. doi: 10.1056/NEJMoa2306963.</cite> [<a href="https://doi.org/10.1056/NEJMoa2306963" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37622681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Semaglutide%20in%20Patients%20with%20Heart%20Failure%20with%20Preserved%20Ejection%20Fraction%20and%20Obesity&amp;author=MN%20Kosiborod&amp;author=SZ%20Abildstr%C3%B8m&amp;author=BA%20Borlaug&amp;volume=389&amp;publication_year=2023&amp;pages=1069-84&amp;pmid=37622681&amp;doi=10.1056/NEJMoa2306963&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Rossing P, Baeres FMM, Bakris G, et al.  The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023;38:2041–51. doi: 10.1093/ndt/gfad009.</cite> [<a href="https://doi.org/10.1093/ndt/gfad009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10469096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36651820/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=The%20rationale,%20design%20and%20baseline%20data%20of%20FLOW,%20a%20kidney%20outcomes%20trial%20with%20once-weekly%20semaglutide%20in%20people%20with%20type%202%20diabetes%20and%20chronic%20kidney%20disease&amp;author=P%20Rossing&amp;author=FMM%20Baeres&amp;author=G%20Bakris&amp;volume=38&amp;publication_year=2023&amp;pages=2041-51&amp;pmid=36651820&amp;doi=10.1093/ndt/gfad009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Cao B, Rosenblat JD, Brietzke E, et al.  Comparative efficacy and acceptability of antidiabetic agents for Alzheimer’s disease and mild cognitive impairment: A systematic review and network meta-analysis. Diabetes Obes Metab. 2018;20:2467–71. doi: 10.1111/dom.13373.</cite> [<a href="https://doi.org/10.1111/dom.13373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29790638/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Obes%20Metab&amp;title=Comparative%20efficacy%20and%20acceptability%20of%20antidiabetic%20agents%20for%20Alzheimer%E2%80%99s%20disease%20and%20mild%20cognitive%20impairment:%20A%20systematic%20review%20and%20network%20meta-analysis&amp;author=B%20Cao&amp;author=JD%20Rosenblat&amp;author=E%20Brietzke&amp;volume=20&amp;publication_year=2018&amp;pages=2467-71&amp;pmid=29790638&amp;doi=10.1111/dom.13373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Tian S, Jiang J, Wang J, et al.  Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis. Diabetes Metab Res Rev. 2023;39:e3673.  doi: 10.1002/dmrr.3673.</cite> [<a href="https://doi.org/10.1002/dmrr.3673" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37302139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Metab%20Res%20Rev&amp;title=Comparison%20on%20cognitive%20outcomes%20of%20antidiabetic%20agents%20for%20type%202%20diabetes:%20A%20systematic%20review%20and%20network%20meta-analysis&amp;author=S%20Tian&amp;author=J%20Jiang&amp;author=J%20Wang&amp;volume=39&amp;publication_year=2023&amp;pages=e3673&amp;pmid=37302139&amp;doi=10.1002/dmrr.3673&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Wu C-Y, Shapiro L, Ouk M, et al.  Glucose-lowering drugs, cognition, and dementia: The clinical evidence. Neurosci Biobehav Rev. 2022;137:104654. doi: 10.1016/j.neubiorev.2022.104654.</cite> [<a href="https://doi.org/10.1016/j.neubiorev.2022.104654" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35398114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosci%20Biobehav%20Rev&amp;title=Glucose-lowering%20drugs,%20cognition,%20and%20dementia:%20The%20clinical%20evidence&amp;author=C-Y%20Wu&amp;author=L%20Shapiro&amp;author=M%20Ouk&amp;volume=137&amp;publication_year=2022&amp;pages=104654&amp;pmid=35398114&amp;doi=10.1016/j.neubiorev.2022.104654&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>Lafaille-Magnan M-E, Poirier J, Etienne P, et al.  Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology (ECronicon) 2017;89:327–35. doi: 10.1212/WNL.0000000000004159.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000004159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5574678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28659431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology%20(ECronicon)&amp;title=Odor%20identification%20as%20a%20biomarker%20of%20preclinical%20AD%20in%20older%20adults%20at%20risk&amp;author=M-E%20Lafaille-Magnan&amp;author=J%20Poirier&amp;author=P%20Etienne&amp;volume=89&amp;publication_year=2017&amp;pages=327-35&amp;pmid=28659431&amp;doi=10.1212/WNL.0000000000004159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Roberts RO, Christianson TJH, Kremers WK, et al.  Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. JAMA Neurol. 2016;73:93–101. doi: 10.1001/jamaneurol.2015.2952.</cite> [<a href="https://doi.org/10.1001/jamaneurol.2015.2952" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4710557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26569387/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Neurol&amp;title=Association%20Between%20Olfactory%20Dysfunction%20and%20Amnestic%20Mild%20Cognitive%20Impairment%20and%20Alzheimer%20Disease%20Dementia&amp;author=RO%20Roberts&amp;author=TJH%20Christianson&amp;author=WK%20Kremers&amp;volume=73&amp;publication_year=2016&amp;pages=93-101&amp;pmid=26569387&amp;doi=10.1001/jamaneurol.2015.2952&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Zhang Z, Zhang B, Wang X, et al.  Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients With Type 2 Diabetes. Diabetes. 2018;67:994–1006. doi: 10.2337/db17-1274.</cite> [<a href="https://doi.org/10.2337/db17-1274" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29500313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes&amp;title=Altered%20Odor-Induced%20Brain%20Activity%20as%20an%20Early%20Manifestation%20of%20Cognitive%20Decline%20in%20Patients%20With%20Type%202%20Diabetes&amp;author=Z%20Zhang&amp;author=B%20Zhang&amp;author=X%20Wang&amp;volume=67&amp;publication_year=2018&amp;pages=994-1006&amp;pmid=29500313&amp;doi=10.2337/db17-1274&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" id="sub-article1"><section class="pmc-layout__citation font-secondary font-xs"><div>BMJ Open. 2025 Aug 21.</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Review Process File</h1></hgroup><ul class="d-buttons inline-list"><li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li></ul>
<div class="d-panels font-secondary-light"><div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div></div>
<div></div>
</div></section><section class="body sub-article-body"><hr class="headless">
<figure class="fig xbox font-sm" id="d67e1969"><div class="media p"><div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-2024-095382.reviewer_comments.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-2024-095382.reviewer_comments.pdf</a><sup> (492.6KB, pdf) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/d67e1969/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adsm93_" lang="en" class="supplementary-materials"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>online supplemental file 1</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s001.pdf</a><sup> (157.7KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>online supplemental file 2</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s002.pdf</a><sup> (383.5KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><span>online supplemental file 3</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12374654/bin/bmjopen-15-8-s003.pdf" data-ga-action="click_feat_suppl" class="usa-link">bmjopen-15-8-s003.pdf</a><sup> (219.4KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.1136/bmjopen-2024-095382</div>
</div></section></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMJ Open are provided here courtesy of <strong>BMJ Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1136/bmjopen-2024-095382"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/bmjopen-15-8.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (494.1 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374654/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374654/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374654%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374654/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374654/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374654/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40840993/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374654/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40840993/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374654/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374654/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="aJ5nvwHhbCYgEUe4iCs8SZr68dGYx61ojzFasOYXCqc5Buwm3p583UJzTpl4YjCO">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
